Page last updated: 2024-08-26

artenimol and Carcinogenesis

artenimol has been researched along with Carcinogenesis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's5 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Li, Y; Liu, W; Tang, J; Wang, Y; Xiao, X; Yang, J; Yue, F; Zhang, Y1
Chai, Z; Li, J; Liu, C; Peng, Y; Qiu, J; Wang, X; Xu, J; Zheng, Y; Zhu, C1
Fan, HN; Peng, SQ; Qu, GQ; Zhang, J; Zhu, JS; Zhu, MY1
Gao, N; He, Q; Ji, J; Li, Y; Liu, J; Ma, L; Wang, Q; Yang, R; Zhou, X1
Chen, S; Han, F; Huang, W; Li, A; Li, Y; Wang, L; Wang, W1

Other Studies

5 other study(ies) available for artenimol and Carcinogenesis

ArticleYear
Dihydroartemisinin inhibits Lewis Lung carcinoma progression by inducing macrophages M1 polarization via AKT/mTOR pathway.
    International immunopharmacology, 2022, Volume: 103

    Topics: Animals; Antineoplastic Agents; Artemisinins; Carcinogenesis; Carcinoma, Lewis Lung; Cell Differentiation; Cytokines; Mice; Mice, Inbred C57BL; Oncogene Protein v-akt; Signal Transduction; Th1 Cells; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Tumor-Associated Macrophages

2022
Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2-RCHY1 mediated signaling pathway.
    Molecular carcinogenesis, 2023, Volume: 62, Issue:3

    Topics: Antineoplastic Agents; Carcinogenesis; Cell Line, Tumor; Colonic Neoplasms; Humans; Oxaliplatin; Signal Transduction; Ubiquitin-Protein Ligases

2023
Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling.
    Pathology, research and practice, 2020, Volume: 216, Issue:2

    Topics: Animals; Artemisinins; Carcinogenesis; Cell Cycle Checkpoints; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Prognosis; Signal Transduction; Stomach; Stomach Neoplasms; Xenograft Model Antitumor Assays

2020
Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
    Life sciences, 2020, May-01, Volume: 248

    Topics: Animals; Antineoplastic Agents, Phytogenic; Artemisinins; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Proteins; Pteridines; Signal Transduction; Smad Proteins; Snail Family Transcription Factors; Transforming Growth Factor beta1; Tumor Burden; Xenograft Model Antitumor Assays

2020
Dihydroartemisinin induces pyroptosis by promoting the AIM2/caspase-3/DFNA5 axis in breast cancer cells.
    Chemico-biological interactions, 2021, May-01, Volume: 340

    Topics: Animals; Apoptosis; Artemisinins; Breast Neoplasms; Carcinogenesis; Caspase 3; Cell Line, Tumor; DNA-Binding Proteins; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Pyroptosis; Receptors, Estrogen

2021